Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi, Michael A. Carducci, Matthew R. Smith, +11

The Lancet

UrologySurgical OncologyMedicineCancer ManagementDouble-blind Study +7

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body, +12

Journal of Clinical Oncology

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

David H. Henry, Luís Costa, François Goldwasser, +15

Journal of Clinical Oncology

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei, Pau Montesinos, Vladimir Ivanov, +21

Blood

Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer

Chao Lin, Hongyong He, Hao Liu, +11

Gut

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator

Steven Snapinn, Qi Jiang, Boris Iglewicz

The American Statistician

Clinical EndpointPrognosisClinical Endpoint TrialsProspective Cohort StudyExtended Kaplan-meier Estimator +22

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion

Qiang Fu, Le Xu, Yiwei Wang, +17

European Urology

Tumor BiologyImmune EvasionCytokineCancer ImmunosurveillanceMedicine +8

Prognostic value of extravascular lung water assessed with lung ultrasound score by chest sonography in patients with acute respiratory distress syndrome

Zhen Zhao, Li Jiang, Xiuming Xi, +5

BMC Pulmonary Medicine

Responder analyses and the assessment of a clinically relevant treatment effect

Steven Snapinn, Qi Jiang

Trials

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow‐up from a phase 1b study

Daniel A. Pollyea, Keith W. Pratz, Anthony Letai, +12

American Journal of Hematology